The FBXW7-binding sites on FAM83D are potential targets for cancer therapy

Xiaoyu Jiang,Yuli Wang,Lulu Guo,Yige Wang,Tianshu Miao,Lijuan Ma,Qin Wei,Xiaoyan Lin,Jian-Hua Mao,Pengju Zhang

DOI: https://doi.org/10.1186/s13058-024-01795-9

2024-03-09

Breast Cancer Research

Abstract:Increasing evidence shows the oncogenic function of FAM83D in human cancer, but how FAM83D exerts its oncogenic function remains largely unclear. Here, we investigated the importance of FAM83D/FBXW7 interaction in breast cancer (BC). We systematically mapped the FBXW7-binding sites on FAM83D through a comprehensive mutational analysis together with co-immunoprecipitation assay. Mutations at the FBXW7-binding sites on FAM83D led to that FAM83D lost its capability to promote the ubiquitination and proteasomal degradation of FBXW7; cell proliferation, migration, and invasion in vitro; and tumor growth and metastasis in vivo, indicating that the FBXW7-binding sites on FAM83D are essential for its oncogenic functions. A meta-evaluation of FAM83D revealed that the prognostic impact of FAM83D was independent on molecular subtypes. The higher expression of FAM83D has poorer prognosis. Moreover, high expression of FAM83D confers resistance to chemotherapy in BCs, which is experimentally validated in vitro. We conclude that identification of FBXW7-binding sites on FAM83D not only reveals the importance for FAM83D oncogenic function, but also provides valuable insights for drug target.

oncology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the interaction between FAM83D and FBXW7 and its mechanism of action in breast cancer (BC). Specifically, the researchers systematically analyzed and experimentally verified the FBXW7 - binding sites on FAM83D and explored the importance of these sites for the oncogenic function of FAM83D. In addition, the study also evaluated the impact of high FAM83D expression on the prognosis of breast cancer patients and its role in chemotherapy resistance. The main objectives of the paper include:

1. **Identify the key sites of the interaction between FAM83D and FBXW7**: Through comprehensive mutational analysis and co - immunoprecipitation experiments, the researchers identified amino acids H343 and L344 on FAM83D as the key sites for binding to FBXW7.

2. **Explore how FAM83D affects the expression of FBXW7 through these sites**: The study found that FAM83D reduces the expression level of FBXW7 by promoting the ubiquitination and proteasome - mediated degradation of FBXW7, and this process depends on the H343 and L344 sites.

3. **Evaluate the role of FAM83D in the proliferation, migration and invasion of breast cancer cells**: The experimental results showed that the H343R/L344A mutant of FAM83D lost the ability to promote cell proliferation, migration and invasion, indicating that the H343 and L344 sites are crucial for the oncogenic function of FAM83D.

4. **Analyze the relationship between high FAM83D expression and the prognosis of breast cancer patients**: Through meta - analysis of clinical data, the study found that high FAM83D expression was significantly associated with poor prognosis in breast cancer patients, including overall survival rate, disease - free survival rate and distant metastasis - free survival rate.

5. **Explore the role of FAM83D in chemotherapy resistance**: The study found that breast cancer cells with high FAM83D expression showed stronger resistance to chemotherapy drugs such as doxorubicin and docetaxel, and knocking down FAM83D could enhance the sensitivity of cells to these drugs.

In summary, this paper aims to reveal the specific mechanism of FAM83D in the development of breast cancer through its interaction with FBXW7 and provide a theoretical basis for the development of new treatment strategies targeting FAM83D.